2021 -
2022 Senior Director Antibody Engineering and Development @
2021 -
2022 Senior Director Antibody Engineering and Development @
2019 -
2020 Director, Protein Design and Molecular Biology @
2017 -
2019 Director, Therapeutic Development @
2016 -
2017 Group Leader, Molecular Biology @
2013 -
2016 Principal Scientist and Group Leader, Antibody Development @
2011 -
2013 Antibody Development Scientist @
2008 -
2011 Instructor @
2004 -
2007 Post-doctoral fellow @
2000 -
2004 PhD student @ college de france
Raphael Rozenfeld Education
Université Paris Cité
PhD (Pharmacochemistry)
2000
-
2004
Université Paris Cité
Pharm.D (Pharmacy)
1993
-
1999
Raphael Rozenfeld Skills
Cell Biology
Cell
Biochemistry
Pharmacology
Cell Culture
Antibodies
Molecular Biology
Transfection
Cell Signaling
Western Blotting
Lifesciences
Biotechnology
Assay Development
Life Sciences
Confocal Microscopy
Tissue Culture
Immunofluorescence
ELISA
Protein Expression
Animal Models
In Vivo
Enzymes
In Vitro
Immunoprecipitation
Fluorescence Microscopy
RT-PCR
SDS-PAGE
qPCR
Immunology
Purification
Enzymology
cannabinoid biology
GPCRs
endocannabinoid
Liver Disease
Bispecific antibodies
Rt Pcr
Clinical Research
Sds Page
Management
Raphael Rozenfeld Summary
Raphael Rozenfeld, based in United States, is currently a Co-Founder, President, and CEO at Wrench Bio. Raphael Rozenfeld brings experience from previous roles at Absci, Totient, Xilio Therapeutics, Inc. and Abexxa Biologics, Inc.. Raphael Rozenfeld holds a 2000 - 2004 PhD in Pharmacochemistry @ Université Paris Cité. With a robust skill set that includes Cell Biology, Cell, Biochemistry, Pharmacology, Cell Culture and more. Raphael Rozenfeld has 2 emails on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.